SHELTER PHARMA LIMITED (SHELTER.BO)
INR 57.5
(0.44%)
INR 57.5
(0.44%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.5 Million | 33 Thousand | 5.17 Million | -2.82 Million | -2.7 Million | - |
| Net Income | 62 Million | 57.83 Million | 18.37 Million | -2.38 Million | 803 Thousand | 601.52 Thousand |
| Depreciation & Amortization | 2.46 Million | 1.64 Million | 1.68 Million | 1.16 Million | 1.31 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -95.09 Million | -82.68 Million | -20.45 Million | -2.18 Million | -2.73 Million | - |
| Other non-cash items | 12.12 Million | 23.24 Million | 5.57 Million | 584 Thousand | -2.09 Million | -601.52 Thousand |
| Investing Cash Flow | -45.44 Million | 1.11 Million | -8.52 Million | 341 Thousand | 2.88 Million | - |
| Investments in PPE | -8.51 Million | -41 Thousand | -6.04 Million | -91 Thousand | -533 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -36.92 Million | 1.15 Million | -2.47 Million | 432 Thousand | 3.41 Million | - |
| Financing Cash Flow | 110.05 Million | 2.14 Million | 648 Thousand | 4.8 Million | - | - |
| Debt repayment | -932 Thousand | -4.15 Million | -648 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 109.12 Million | -2.01 Million | - | 4.8 Million | - | - |
| Accounts receivables | -6.55 Million | -65.89 Million | -8.46 Million | -1.45 Million | -5.5 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -20.65 Million | -22.9 Million | -16.59 Million | 2.91 Million | -1.81 Million | - |
| Other working capital | -67.88 Million | 6.1 Million | 4.59 Million | -3.63 Million | 4.58 Million | - |
| Cash at beginning of period | 4.28 Million | 1 Million | 3.7 Million | 1.38 Million | 1.21 Million | - |
| Cash at end of period | 50.39 Million | 4.28 Million | 1 Million | 3.7 Million | 1.38 Million | - |
| Capital Expenditure | -8.51 Million | -41 Thousand | -6.04 Million | -91 Thousand | -533 Thousand | - |
| Effect of forex changes on cash | - | -1000.00 | -1000.00 | - | - | - |
| Net cash flow / Change in cash | 46.11 Million | 3.28 Million | -2.7 Million | 2.31 Million | 176 Thousand | - |
| Free Cash Flow | -27.02 Million | -8000.00 | -877 Thousand | -2.91 Million | -3.24 Million | - |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 15.49 Million | 62 Million | 15.49 Million | 15.5 Million | 15.5 Million | 8.42 Million |
| Depreciation & Amortization | 631 Thousand | 2.46 Million | 631 Thousand | 599 Thousand | 599 Thousand | 543 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 25.91 Million | -95.08 Million | 25.91 Million | -73.46 Million | -73.46 Million | -18.31 Million |
| Other non-cash items | 2.14 Million | 12.12 Million | 2.14 Million | 3.92 Million | 3.92 Million | 5.03 Million |
| Investing Cash Flow | -22.5 Million | -45.44 Million | -22.5 Million | -216.5 Thousand | -216.5 Thousand | 2.84 Million |
| Investments in PPE | -3.9 Million | -8.51 Million | -3.9 Million | -356 Thousand | -356 Thousand | -27 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -18.6 Million | -36.92 Million | -18.6 Million | 139.5 Thousand | 139.5 Thousand | 2.87 Million |
| Financing Cash Flow | -17.11 Million | 110.05 Million | -17.11 Million | 72.14 Million | 72.14 Million | 2.64 Million |
| Debt repayment | - | -932 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -19.97 Million | - | -19.97 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.86 Million | 109.12 Million | 2.86 Million | 72.14 Million | 72.14 Million | 2.64 Million |
| Accounts receivables | 3.19 Million | -6.55 Million | 3.19 Million | -6.46 Million | -6.46 Million | -3.93 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -4.13 Million | -20.65 Million | -4.13 Million | -6.19 Million | -6.19 Million | -16.22 Million |
| Other working capital | 26.86 Million | -67.88 Million | 26.86 Million | -60.8 Million | -60.8 Million | 1.85 Million |
| Cash at beginning of period | - | 4.28 Million | - | - | 4.28 Million | - |
| Cash at end of period | 4.56 Million | 50.39 Million | 4.56 Million | 18.49 Million | - | 4.28 Million |
| Capital Expenditure | -3.9 Million | -8.51 Million | -3.9 Million | -356 Thousand | -356 Thousand | -27 Thousand |
| Effect of forex changes on cash | - | - | - | - | -22.77 Million | 3.1 Million |
| Net cash flow / Change in cash | 4.56 Million | 46.11 Million | 4.56 Million | 18.49 Million | -4.28 Million | 4.28 Million |
| Free Cash Flow | 40.27 Million | -27.02 Million | 40.27 Million | -53.78 Million | -53.78 Million | -4.33 Million |
6637
AEON
9898
CRDO
TITMF
ACM